666 related articles for article (PubMed ID: 17619828)
1. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.
Rahimi Z; Ghaderi M; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Dec; 26(3):229-33. PubMed ID: 17982733
[TBL] [Abstract][Full Text] [Related]
6. Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.
Isma'eel H; Arnaout MS; Shamseddeen W; Mahfouz R; Zeineh N; Jradi O; Taher A
J Thromb Thrombolysis; 2006 Oct; 22(2):121-3. PubMed ID: 17008978
[TBL] [Abstract][Full Text] [Related]
7. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
8. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
[TBL] [Abstract][Full Text] [Related]
9. Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern Iran.
Rahimi Z; Vaisi-Raygani A; Pourmotabbed T
Mol Biol Rep; 2011 Feb; 38(2):703-10. PubMed ID: 20373031
[TBL] [Abstract][Full Text] [Related]
10. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
11. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY
Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
13. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease.
Moreira Neto F; Lourenço DM; Noguti MA; Morelli VM; Gil IC; Beltrão AC; Figueiredo MS
Braz J Med Biol Res; 2006 Oct; 39(10):1291-5. PubMed ID: 16906320
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.
Pandey SK; Meena A; Kishor K; Mishra RM; Pandey S; Saxena R
Clin Appl Thromb Hemost; 2012 Jun; 18(3):320-3. PubMed ID: 22084413
[TBL] [Abstract][Full Text] [Related]
15. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
[TBL] [Abstract][Full Text] [Related]
16. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease.
Samarah F; Srour MA
BMC Hematol; 2018; 18():1. PubMed ID: 29372059
[TBL] [Abstract][Full Text] [Related]
19. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
[TBL] [Abstract][Full Text] [Related]
20. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
Huber S; McMaster KJ; Voelkerding KV
J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
